SCC Vaping ยท Business & collaboration pathway

Business and partnership due diligence

A factual, non-promotional route for prospective partners to evaluate scientific independence, operating capabilities, data governance and commercial readiness.

Submission-stage disclosure. SCC Vaping has not claimed journal acceptance, independent peer-review approval, verified clinical efficacy, regulatory certification or a published business valuation. Public material is deliberately limited to documented facts, provisional evidence status and release-safe summaries.

Collaboration mandate

Independent evidence infrastructure

SCC Vaping provides a demonstrable public-interest research-engineering capability, not a clinically validated product, an investment prospectus or a claim that any vaping product is safe.

Current operating capabilities

Registered-source ingestion, deterministic quality gates, deduplication, source linkage, reproducible release manifests, curated public metadata and reviewer-controlled workflows.

Research collaboration

Academics, policy researchers, institutions and technical partners may propose jointly scoped methods validation, external review and interoperability work.

Potential service boundaries

Custom observatory engineering, lawful evidence surveillance and structured analysis may be explored only with separately agreed scope, rights, costs, deliverables and independence safeguards.

Conflict and funding rules

Any sponsor, financial interest, advocacy interest or third-party influence must be disclosed. No undisclosed sponsor endorsement is implied.

Submission and due-diligence requirements

TopicCurrent positionNeeded before formal business reliance
Technical availabilityPublic release operationalIndependent security, service and continuity verification
Scientific claimsNot certified or peer-review acceptedQualified independent review, frozen results and explicit limitations
Market forecasts and revenueNo verified financial figures publishedAudited assumptions, unit economics and financial review
IP, datasets and copyrightRights require component-level reviewPermissions and commercial reuse agreements
Privacy and contractsRestricted material excluded from public pagesWritten lawful-basis, DPIA where required and contractual safeguards

No claimed market size, revenue, valuation, formal sponsor, regulatory endorsement or undisclosed commercial data is included.